Presbyopia eye drop in final stage of clinical development
An ophthalmic pharmaceutical company has commenced two Phase 3 clinical studies to evaluate its eye drop candidate for presbyopia. Approximately ...
Tag: NEAR-1 and NEAR-2
An ophthalmic pharmaceutical company has commenced two Phase 3 clinical studies to evaluate its eye drop candidate for presbyopia. Approximately ...